clinical trial · NCT07341672
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Sunshine Lake Pharma Co., Ltd.·phase1·not yet recruiting·n = 80
Healthy Adult SubjectClifutinibItraconazolefluconazoleefavirenz
brief summary
Evaluate the pharmacokinetic effects of itraconazole, fluconazole, or efavirenz on a single - dose of Clifutinib and the safety of the combination therapy in healthy participants.
started
Mar 4, 2026
primary completion
Apr 23, 2026
completion
May 8, 2026
last updated
Jan 14, 2026
official title
The Drug-Drug Interaction Study of Clifutinib
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol